QNXT - ETF AI Analysis
Top Page
iShares Nasdaq-100 ex Top 30 ETF (QNXT)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, showing positive momentum over the longer recent period.
Healthy Top Holdings Performance
Several of the largest positions, especially in technology and health care, have shown strong or steady performance, helping support the fund’s returns.
Broad Sector Diversification
The fund is spread across many sectors, including technology, health care, consumer, industrials, and utilities, which helps reduce the impact of weakness in any single industry.
Negative Factors
Recent Short-Term Weakness
The ETF has slipped over the past month, indicating some short-term volatility that investors should be prepared for.
High U.S. Market Concentration
Almost all of the fund’s holdings are in U.S. companies, offering very limited geographic diversification outside the United States.
Mixed Performance Among Top Holdings
A few of the largest positions have been weak or lagging recently, which can drag on overall fund performance if those stocks continue to struggle.
QNXT vs. SPDR S&P 500 ETF (SPY)
AUM27.75M
RegionNorth America
Expense Ratio0.20%
Beta1.05
IssueriShares
Inception DateOct 23, 2024
Dividend Yield0.69%
Asset ClassEquity
Index TrackedNasdaq-100 ex Top 30 Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,181
30 Day Avg. Volume7,134
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.26Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering71
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QNXT Summary
QNXT is an ETF that follows the Nasdaq-100 ex Top 30 Index, meaning it invests in the next tier of large companies in the Nasdaq, not the biggest household names. It mainly holds U.S. stocks in technology, healthcare, and consumer businesses. Well-known companies in the fund include Amgen and ASML. Investors might consider QNXT if they want growth potential from innovative firms while avoiding heavy concentration in the very largest tech giants. However, because it focuses on stock markets and sectors like technology, its value can go up and down with market swings.
How much will it cost me?The iShares Nasdaq-100 ex Top 30 ETF (QNXT) has an expense ratio of 0.20%, meaning you’ll pay $2 per year for every $1,000 invested. This cost is lower than average for actively managed funds but slightly higher than many passively managed ETFs, as it focuses on a unique niche within the Nasdaq-100 Index.
What would affect this ETF?The QNXT ETF, with its focus on large-cap companies in technology, healthcare, and consumer sectors, could benefit from continued innovation and growth in these industries, especially as emerging leaders gain market share. However, it may face challenges from rising interest rates, which can impact growth-oriented stocks, and economic slowdowns that could affect consumer spending and corporate investments. Additionally, regulatory changes in the tech and healthcare sectors could create uncertainty for some of its top holdings.
QNXT Top 10 Holdings
QNXT leans heavily into U.S. tech and health care, with mid-tier Nasdaq names doing most of the heavy lifting. Chip and hardware plays like Western Digital and Marvell have been key engines over the year, even if their recent momentum has cooled, while ASML adds steady strength to the semiconductor theme. On the health care side, Amgen and Gilead are quietly supporting returns with rising, if unspectacular, performance. Offsetting that, Shopify, Booking Holdings, and Intuitive Surgical have been losing steam, dragging on results and reminding investors that this “next tier” Nasdaq basket can be a mixed ride.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amgen | 3.89% | $1.07M | $202.95B | 22.66% | 77 Outperform | |
| Western Digital | 3.44% | $948.63K | $179.17B | 655.30% | 77 Outperform | |
| Marvell | 3.26% | $900.64K | $170.10B | 161.73% | 76 Outperform | |
| ASML Holding | 3.09% | $852.19K | $681.41B | 147.04% | 81 Outperform | |
| Gilead Sciences | 3.08% | $850.34K | $160.55B | 11.28% | 78 Outperform | |
| Shopify | 2.66% | $733.91K | $147.98B | -8.58% | 77 Outperform | |
| Booking Holdings | 2.64% | $727.59K | $137.51B | -21.23% | 63 Neutral | |
| Vertex Pharmaceuticals | 2.32% | $640.14K | $121.16B | 1.64% | 78 Outperform | |
| Intuitive Surgical | 2.30% | $634.16K | $119.23B | -31.94% | 78 Outperform | |
| Starbucks | 2.26% | $622.80K | $117.67B | 9.35% | 56 Neutral |
QNXT Technical Analysis
Negative
―
Price Trends
30.78
Negative
29.17
Positive
28.42
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QNXT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 30.79, equal to the 50-day MA of 30.78, and equal to the 200-day MA of 28.42, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QNXT.
QNXT Peer Comparison
Comparison Results
Performance Comparison
QNXT
iShares Nasdaq-100 ex Top 30 ETF
30.00
3.34
12.53%
ACEP
ARS Core Equity Portfolio ETF
―
―
―
JOYT
JPMorgan Equity and Options Total Return ETF
―
―
―
ALTL
Pacer Lunt Large Cap Alternator ETF
―
―
―
JHDG
John Hancock Hedged Equity ETF
―
―
―
FCUS
Pinnacle Focused Opportunities ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents